TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 11591494

Group type: EXPERIMENTAL
Intervention: Nicotine (transdermal administration)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20
Study: 9673474

Group type: EXPERIMENTAL
Intervention: Hypertensive patients (stages 2, 3, and 4)
Number of subjects: 45

Group type: COMPARATOR
Intervention: Normal subjects and stage 0 and stage 1 hypertensive retinopathy patients
Number of subjects: 45
Study: 8207039

Group type: EXPERIMENTAL
Intervention: Catheters coated with CH alone
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Catheters coated with CH with or without HEP
Number of subjects: 30

Group type: COMPARATOR
Intervention: Catheters coated with CH/HEP
Number of subjects: 30

Group type: COMPARATOR
Intervention: Catheters coated with CH
Number of subjects: 30
Study: 2914008

Group type: EXPERIMENTAL
Intervention: Progressive relaxation
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Stimulus control
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Paradoxical intention
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0

Group type: COMPARATOR
Intervention: No treatment
Number of subjects: 0
Study: 1102260

Group type: EXPERIMENTAL
Intervention: Methocarbamol (1500 mg. q.d.s.)
Number of subjects: 59

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 59
Study: 31545799

Group type: EXPERIMENTAL
Intervention: Diazoxide Choline Controlled-Release Tablets (DCCR)
Number of subjects: 13
Study: 28260689

Group type: EXPERIMENTAL
Intervention: Foley catheter filled with 30mL
Number of subjects: 174

Group type: EXPERIMENTAL
Intervention: Foley catheter filled with 60mL
Number of subjects: 174

Group type: COMPARATOR
Intervention: Foley catheter filled with 30mL and 60mL
Number of subjects: 174
Study: 25126675

Group type: EXPERIMENTAL
Intervention: Resin infiltration (Icon, DMG, Hamburg, Germany)
Number of subjects: 20
Study: 21824756

Group type: EXPERIMENTAL
Intervention: Cocoa powder with water (CW)
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Cocoa powder with milk (CM)
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Only milk (M)
Number of subjects: 18
Study: 21296261

Group type: EXPERIMENTAL
Intervention: Tai chi Qigong (TCQ) program, two 60-min sessions each week for three months
Number of subjects: 206

Group type: EXPERIMENTAL
Intervention: Breathing techniques combined with walking as an exercise
Number of subjects: 206

Group type: COMPARATOR
Intervention: Usual activities
Number of subjects: 206
Study: 19964499

Group type: EXPERIMENTAL
Intervention: Therapist-mediated post-stroke rehabilitation using haptic/graphic error augmentation
Number of subjects: 0
Study: 16579706

Group type: EXPERIMENTAL
Intervention: Titanium healing caps
Number of subjects: 5

Group type: COMPARATOR
Intervention: Zirconium oxide healing caps
Number of subjects: 5

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 5
Study: 12928471

Group type: EXPERIMENTAL
Intervention: C-reactive protein
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: lipoprotein(a)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: fibrinogen
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: homocysteine
Number of subjects: 0
Study: 16505324

Group type: EXPERIMENTAL
Intervention: LY450139 dihydrate 30 mg for 1 week followed by 40 mg for 5 weeks
Number of subjects: 70
Study: 10575563

Group type: EXPERIMENTAL
Intervention: Tauroursodeoxycholic acid (250 b.i.d. for 12 months)
Number of subjects: 33

Group type: COMPARATOR
Intervention: Control group (17 patients)
Number of subjects: 33

Group type: EXPERIMENTAL
Intervention: Tauroursodeoxycholic acid
Number of subjects: 33
Study: 8916695

Group type: EXPERIMENTAL
Intervention: Ultrasound guided fine needle aspiration
Number of subjects: 278

Group type: COMPARATOR
Intervention: Simple observation
Number of subjects: 278
Study: 2006723

Group type: EXPERIMENTAL
Intervention: Bupivacaine (20 ml 0.25% every 4 h)
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Bupivacaine plus epinephrine 1:200,000
Number of subjects: 10

Group type: COMPARATOR
Intervention: Bupivacaine alone
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Bupivacaine (with epinephrine)
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Bupivacaine
Number of subjects: 10
Study: 7096279

Group type: EXPERIMENTAL
Intervention: Doxepin HCl (50 mg h.s.)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Cimetidine (1000 mg/day in divided doses)
Number of subjects: 50
Study: 31071047

Group type: EXPERIMENTAL
Intervention: 3D-DHD (three-dimensional printed dynamic hand device) used twice a week for four weeks, followed by a two-week home program
Number of subjects: 10

Group type: COMPARATOR
Intervention: Control group (only task-oriented approach without 3D-DHD)
Number of subjects: 10
Study: 28828866

Group type: EXPERIMENTAL
Intervention: Role-play intervention
Number of subjects: 8

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 8
Study: 26956164

Group type: EXPERIMENTAL
Intervention: Three randomly ordered slightly different 140 character or less messages containing a short URL to the freely accessible summary page sent on specific times on one single day
Number of subjects: 170

Group type: COMPARATOR
Intervention: No messaging
Number of subjects: 170
Study: 24324045

Group type: EXPERIMENTAL
Intervention: Antioxidant cocktail (vitamin C, vitamin E, α‐lipoic acid)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 30
Study: 22877086

Group type: EXPERIMENTAL
Intervention: Neurofeedback (NF)
Number of subjects: 91

Group type: COMPARATOR
Intervention: Methylphenidate
Number of subjects: 91

Group type: EXPERIMENTAL
Intervention: Neurofeedback (NF) + Methylphenidate
Number of subjects: 91
Study: 19417110

Group type: EXPERIMENTAL
Intervention: Valsartan (mean dose 114 +/- 41 mg/day)
Number of subjects: 27

Group type: EXPERIMENTAL
Intervention: Valsartan
Number of subjects: 27

Group type: COMPARATOR
Intervention: ACE inhibitor therapy
Number of subjects: 27
Study: 17413835

Group type: EXPERIMENTAL
Intervention: Intervention group with tailored assessment and interventions for heel pressure ulcer prevention.
Number of subjects: 242

Group type: COMPARATOR
Intervention: Control group receiving standard care without tailored interventions.
Number of subjects: 242

Group type: EXPERIMENTAL
Intervention: Trial heel pressure relief device used in the intervention group.
Number of subjects: 242
Study: 15336471

Group type: EXPERIMENTAL
Intervention: Cizolirtine citrate 350 mg IV
Number of subjects: 64

Group type: COMPARATOR
Intervention: Metamizol sodium 2,500 mg IV
Number of subjects: 64
Study: 11245323

Group type: EXPERIMENTAL
Intervention: Influenza vaccination
Number of subjects: 39

Group type: COMPARATOR
Intervention: Control group (no vaccination)
Number of subjects: 39
Study: 9730125

Group type: EXPERIMENTAL
Intervention: Foot pump (A-V Impulse System) for 7 days
Number of subjects: 290

Group type: COMPARATOR
Intervention: Low-molecular-weight heparin (enoxaparin 40 mg daily) for 7 days
Number of subjects: 290

Group type: EXPERIMENTAL
Intervention: Foot pump
Number of subjects: 290

Group type: COMPARATOR
Intervention: Low-molecular-weight heparin
Number of subjects: 290
Study: 7973479

Group type: EXPERIMENTAL
Intervention: Fluoxetine 20 mg/day
Number of subjects: 42

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 42
Study: 30837573

Group type: EXPERIMENTAL
Intervention: Hydrogen peroxide (H2O2) whitening products
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: 35% H2O2 bleaching
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Lower concentrations of H2O2
Number of subjects: 0
Study: 28461256

Group type: EXPERIMENTAL
Intervention: Veliparib (120 mg) with carboplatin/paclitaxel
Number of subjects: 158

Group type: COMPARATOR
Intervention: Placebo with carboplatin/paclitaxel
Number of subjects: 158
Study: 25407380

Group type: EXPERIMENTAL
Intervention: Multicomponent training (aerobic, strength, and balance exercises)
Number of subjects: 69

Group type: EXPERIMENTAL
Intervention: Resistance training (strength exercises using six machines)
Number of subjects: 69

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 69
Study: 22858264

Group type: EXPERIMENTAL
Intervention: DBT-based psychoeducational group (BDG) intervention consisting of 12 weekly 90-min sessions teaching DBT skills, mindfulness techniques, and general BD psychoeducation.
Number of subjects: 26

Group type: COMPARATOR
Intervention: Wait-list control group.
Number of subjects: 26
Study: 21163686

Group type: EXPERIMENTAL
Intervention: Visible-light therapy (VLT) device
Number of subjects: 20

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20
Study: 19089699

Group type: EXPERIMENTAL
Intervention: Health PSAs (public service announcements) focusing on nutrition, physical activity, and hand washing
Number of subjects: 0

Group type: COMPARATOR
Intervention: Nonviewing counterparts (control group)
Number of subjects: 0
Study: 17199681

Group type: EXPERIMENTAL
Intervention: Living bilayered skin construct (BSC)
Number of subjects: 177

Group type: COMPARATOR
Intervention: Conventional therapy (compression alone)
Number of subjects: 177

Group type: EXPERIMENTAL
Intervention: Wound Bed Score (WBS)
Number of subjects: 177

Group type: EXPERIMENTAL
Intervention: Wound Bed Score (WBS) quartile groups
Number of subjects: 177
Study: 12599230

Group type: EXPERIMENTAL
Intervention: Liposomal daunorubicin and ara-C (DA)
Number of subjects: 84

Group type: EXPERIMENTAL
Intervention: Liposomal daunorubicin and ara-C with thalidomide (DATh)
Number of subjects: 84

Group type: COMPARATOR
Intervention: Liposomal daunorubicin and topotecan (DT)
Number of subjects: 84

Group type: COMPARATOR
Intervention: Liposomal daunorubicin and topotecan with thalidomide (DTTh)
Number of subjects: 84
Study: 10674229

Group type: EXPERIMENTAL
Intervention: Hyperinsulinemia (Study I)
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Hyperinsulinemia with maintenance of basal plasma AA and branched-chain KA concentrations (Study II)
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Hyperinsulinemia with hyperaminoacidemia and basal plasma branched-chain KA concentrations (Study III)
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Hyperinsulinemia plus basal plasma AA concentrations and elevated branched-chain KA levels (Study IV)
Number of subjects: 8
Study: 9179456

Group type: EXPERIMENTAL
Intervention: Transdermal estradiol (0.05 mg/day x 21 days) and oral progestogens (10 mg/day medroxyprogesterone acetate [MPA] in the last 12 days, 10 mg/day dihydrogesterone in the last 12 days, and 50 mg/day cyproterone in the first 10 days)
Number of subjects: 38
Study: 8456474

Group type: EXPERIMENTAL
Intervention: TDIS with OKT3 (group II)
Number of subjects: 129

Group type: EXPERIMENTAL
Intervention: TDIS with LO-Tact-1 (group III)
Number of subjects: 129

Group type: COMPARATOR
Intervention: TDIS only (group I)
Number of subjects: 129
Study: 3531033

Group type: EXPERIMENTAL
Intervention: Captopril (Aceten) 150 mg/day
Number of subjects: 39

Group type: COMPARATOR
Intervention: M-dopa 750 mg/day
Number of subjects: 39
Study: 30282510

Group type: EXPERIMENTAL
Intervention: Nexodyn solution on top of standard of care
Number of subjects: 50

Group type: COMPARATOR
Intervention: Standard of care
Number of subjects: 50
Study: 28035345

Group type: EXPERIMENTAL
Intervention: High-flavonoid fruit and vegetables (>15 mg/100 g)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Low-flavonoid fruit and vegetables (<5 mg/100 g)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: High-flavanol cocoa drink (494 mg total flavanols)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Low-flavanol cocoa drink (23 mg total flavanols)
Number of subjects: 0
Study: 24393456

Group type: EXPERIMENTAL
Intervention: Varenicline (2 mg)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 22892813

Group type: EXPERIMENTAL
Intervention: High flavanols (≈990 mg per day)
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Intermediate flavanols (≈520 mg per day)
Number of subjects: 90

Group type: COMPARATOR
Intervention: Low flavanols (≈45 mg per day)
Number of subjects: 90
Study: 20635829

Group type: EXPERIMENTAL
Intervention: Generic medication voucher program providing a 30-day supply of 8 specific medications in addition to academic detailing.
Number of subjects: 108

Group type: COMPARATOR
Intervention: Academic detailing alone (control group).
Number of subjects: 108

Group type: EXPERIMENTAL
Intervention: Generic medication voucher program.
Number of subjects: 108
Study: 19273915

Group type: EXPERIMENTAL
Intervention: Articaine 4% with epinephrine 1:100,000
Number of subjects: 30

Group type: COMPARATOR
Intervention: Lidocaine 2% with epinephrine 1:100,000
Number of subjects: 30
Study: 15681592

Group type: EXPERIMENTAL
Intervention: Tailored smoking cessation intervention using AHCPR guideline with brief nurse-assisted counseling and follow-up telephone support.
Number of subjects: 401

Group type: COMPARATOR
Intervention: Control group (201 patients) without the tailored intervention.
Number of subjects: 401

Group type: EXPERIMENTAL
Intervention: Tailored smoking cessation intervention for younger smokers (aged 49 or less).
Number of subjects: 401

Group type: EXPERIMENTAL
Intervention: Tailored smoking cessation intervention for older smokers (aged 50 or more).
Number of subjects: 401
Study: 12629093

Group type: EXPERIMENTAL
Intervention: 25 mg DHEA (n = 19)
Number of subjects: 39

Group type: COMPARATOR
Intervention: Placebo (n = 20)
Number of subjects: 39

Group type: EXPERIMENTAL
Intervention: 25 mg DHEA
Number of subjects: 39
Study: 10475655

Group type: EXPERIMENTAL
Intervention: Methylprednisolone 250 mg at induction of anaesthesia, with a further three doses at 6-hourly intervals postoperatively
Number of subjects: 20

Group type: COMPARATOR
Intervention: Placebo (identically packaged)
Number of subjects: 20
Study: 8738766

Group type: EXPERIMENTAL
Intervention: IMx assay for FK506 in whole blood samples
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Blinded samples
Number of subjects: 40
Study: 1751266

Group type: EXPERIMENTAL
Intervention: Propofol and midazolam combination
Number of subjects: 200

Group type: COMPARATOR
Intervention: Propofol alone
Number of subjects: 200

Group type: COMPARATOR
Intervention: Midazolam alone
Number of subjects: 200

Group type: EXPERIMENTAL
Intervention: Combination of propofol and midazolam
Number of subjects: 200
Study: 7103030

Group type: EXPERIMENTAL
Intervention: Fentanyl with halothane anaesthesia
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Fentanyl with enflurane anaesthesia
Number of subjects: 0

Group type: COMPARATOR
Intervention: Fentanyl with various anaesthetic agents
Number of subjects: 0
Study: 29528181

Group type: EXPERIMENTAL
Intervention: Busulfan-cyclophosphamide-melphalan (Bu-Cy-Mel)
Number of subjects: 27

Group type: EXPERIMENTAL
Intervention: Busulfan-fludarabine (Bu-Flu)
Number of subjects: 27

Group type: COMPARATOR
Intervention: Both interventions (Bu-Cy-Mel and Bu-Flu)
Number of subjects: 27
Study: 27630318

Group type: EXPERIMENTAL
Intervention: Capecitabine (CCB) alone (1,000 mg/m2 bid p.o.)
Number of subjects: 24

Group type: COMPARATOR
Intervention: Capecitabine (CCB) plus Cetuximab (CTX) (loading dose 400 mg/m2 followed by 250 mg/m2 weekly i.v. maintenance dose)
Number of subjects: 24
Study: 25158772

Group type: EXPERIMENTAL
Intervention: Dual antiplatelet therapy with clopidogrel and aspirin
Number of subjects: 3020

Group type: COMPARATOR
Intervention: Aspirin
Number of subjects: 3020

Group type: EXPERIMENTAL
Intervention: Nonfatal major hemorrhage
Number of subjects: 3020
Study: 21839429

Group type: EXPERIMENTAL
Intervention: Group B: 40 mg triamcinolone, 2 ml bupivicaine, and 6 ml sterile water for injection
Number of subjects: 110

Group type: COMPARATOR
Intervention: Group A: 40 mg triamcinolone and 2 ml bupivicaine
Number of subjects: 110
Study: 20421430

Group type: COMPARATOR
Intervention: 1.5% dextrose solution
Number of subjects: 13

Group type: EXPERIMENTAL
Intervention: 1.1% amino acid solution
Number of subjects: 13
Study: 18287602

Group type: EXPERIMENTAL
Intervention: Decompressive surgery
Number of subjects: 654

Group type: COMPARATOR
Intervention: Usual nonsurgical care
Number of subjects: 654

Group type: EXPERIMENTAL
Intervention: Combined as-treated analysis (surgery)
Number of subjects: 654
Study: 15807814

Group type: EXPERIMENTAL
Intervention: Pointed microneedle injections
Number of subjects: 11

Group type: EXPERIMENTAL
Intervention: Symmetric microneedle injections
Number of subjects: 11

Group type: COMPARATOR
Intervention: Topical application (TA)
Number of subjects: 11
Study: 12747504

Group type: EXPERIMENTAL
Intervention: Decision time as a measure of conflict strength
Number of subjects: 0
Study: 10850522

Group type: EXPERIMENTAL
Intervention: Intravenous gatifloxacin 400 mg
Number of subjects: 24

Group type: COMPARATOR
Intervention: Oral gatifloxacin 400 mg
Number of subjects: 24
Study: 8790227

Group type: EXPERIMENTAL
Intervention: Recombinant human growth hormone at a dose of 0.025 mg/kg body weight/day administered by daily subcutaneous injection over a 6-month study period
Number of subjects: 33

Group type: COMPARATOR
Intervention: Estrogen (not specified dosage or duration)
Number of subjects: 33

Group type: COMPARATOR
Intervention: Younger women (20 to 40 years)
Number of subjects: 33
Study: 1637766

Group type: EXPERIMENTAL
Intervention: TENS (Transcutaneous Electrical Nerve Stimulation)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Local anaesthetic (2% lignocaine and 0.03 iu/ml octopressin)
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: TENS plus local anaesthetic
Number of subjects: 100
Study: 6398314

Group type: EXPERIMENTAL
Intervention: Thymopentin 50 mg, i.v., 3 times a week for 3 consecutive weeks
Number of subjects: 41

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 41

Group type: EXPERIMENTAL
Intervention: Thymopentin
Number of subjects: 41
Study: 30963239

Group type: EXPERIMENTAL
Intervention: HIIT (4 × 4‐min intervals)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: ST (five body‐weight exercises)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: MCT (continuous cycling)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Squats (part of ST)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Push-ups (part of ST)
Number of subjects: 12
Study: 28270276

Group type: EXPERIMENTAL
Intervention: 70 kV group (n=20)
Number of subjects: 40

Group type: COMPARATOR
Intervention: 100 kV group (n=20)
Number of subjects: 40
Study: 27798038

Group type: EXPERIMENTAL
Intervention: Community-based exercise (CBE) intervention, 24-week program including aerobic, resistance, balance, and flexibility exercise at the YMCA, 3 times per week with supervision and educational sessions.
Number of subjects: 0
Study: 24441150

Group type: EXPERIMENTAL
Intervention: adalimumab + MTX
Number of subjects: 333

Group type: COMPARATOR
Intervention: placebo + MTX
Number of subjects: 333
Study: 22079469

Group type: EXPERIMENTAL
Intervention: Oral beclomethasone dipropionate (BDP) administered as 1-mg immediate-release formulation plus 1-mg delayed-release formulation orally four times daily.
Number of subjects: 138

Group type: COMPARATOR
Intervention: Placebo administered as per the study design.
Number of subjects: 138

Group type: EXPERIMENTAL
Intervention: Overall adherence to the study drug during the first 4 weeks after hematopoietic cell transplantation.
Number of subjects: 138

Group type: EXPERIMENTAL
Intervention: Adherence to the study drug schedule.
Number of subjects: 138
Study: 19153943

Group type: EXPERIMENTAL
Intervention: paroxetine
Number of subjects: 77

Group type: EXPERIMENTAL
Intervention: amitriptyline
Number of subjects: 77

Group type: COMPARATOR
Intervention: drug-free
Number of subjects: 77

Group type: EXPERIMENTAL
Intervention: free IGF-I
Number of subjects: 77
Study: 17156883

Group type: EXPERIMENTAL
Intervention: Midodrine 10mg, t.i.d. for 7 days
Number of subjects: 39

Group type: EXPERIMENTAL
Intervention: Midodrine 10mg, t.i.d. for 7 days (in patients with ascites)
Number of subjects: 39

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 39
Study: 16335037

Group type: COMPARATOR
Intervention: TG0 (no coronal walls)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: TG1 (one coronal wall)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: TG2 (two coronal walls)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: TG3 (three coronal walls)
Number of subjects: 40
Study: 10961470

Group type: COMPARATOR
Intervention: Urodynamic examination before and after delayed treatment starting 6 months after inclusion in the study (Control group)
Number of subjects: 87

Group type: EXPERIMENTAL
Intervention: Urodynamic examination only after the final outcome evaluation at 12 months (Intervention group)
Number of subjects: 87
Study: 9194908

Group type: EXPERIMENTAL
Intervention: Alcohol-flavored human milk
Number of subjects: 0

Group type: COMPARATOR
Intervention: Unaltered human milk
Number of subjects: 0
Study: 1553612

Group type: EXPERIMENTAL
Intervention: Nasogastric tube
Number of subjects: 109

Group type: COMPARATOR
Intervention: No nasogastric tube
Number of subjects: 109
Study: 3158563

Group type: EXPERIMENTAL
Intervention: Fominoben (PB89) - 160 mg, 3 times a day for 2 weeks
Number of subjects: 60

Group type: COMPARATOR
Intervention: Dextromethorphan - 30 mg, 3 times a day for 2 weeks
Number of subjects: 60
Study: 29398337

Group type: EXPERIMENTAL
Intervention: 80 g/d prunes (plus 300 ml/d water)
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: 120 g/d prunes (plus 300 ml/d water)
Number of subjects: 120

Group type: COMPARATOR
Intervention: Control (300 ml/d water)
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: 80 g/d prunes
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: 120 g/d prunes
Number of subjects: 120

Group type: COMPARATOR
Intervention: Control
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Prune consumption
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Prunes
Number of subjects: 120
Study: 29504445

Group type: EXPERIMENTAL
Intervention: Intermittent pneumatic compression therapy in addition to conventional postoperative rehabilitation
Number of subjects: 115

Group type: COMPARATOR
Intervention: Conventional postoperative rehabilitation without intermittent pneumatic compression therapy
Number of subjects: 115
Study: 27450411

Group type: EXPERIMENTAL
Intervention: Azithromycin maintenance therapy (250/500 mg according to body weight) administered three times a week for 6 months
Number of subjects: 125

Group type: EXPERIMENTAL
Intervention: Azithromycin maintenance therapy
Number of subjects: 125

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 125
Study: 23290692

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 486
Study: 20648883

Group type: EXPERIMENTAL
Intervention: Structured comprehensive oral health education (SC‐OHE)
Number of subjects: 4210

Group type: COMPARATOR
Intervention: Conventional oral health education (Control Group)
Number of subjects: 4210
Study: 18386538

Group type: EXPERIMENTAL
Intervention: Etoricoxib (120 mg, tablet)
Number of subjects: 80

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 80